Perfect Medical Industry Co., Ltd.
Perfect Medical Industry Co., Ltd. manufactures and sells health and medical supplies in Taiwan and internationally. It provides hemodialysis blood tubing sets, A.V. fistula needle sets, huber needle/winged needle sets, blood transfusion sets, safety infusion sets, safety extension sets, I.V. locks, and medical face masks, as well as disposable syringes. The company also offers its products under… Read more
Perfect Medical Industry Co., Ltd. (6543) - Net Assets
Latest net assets as of June 2025: NT$757.61 Million TWD
Based on the latest financial reports, Perfect Medical Industry Co., Ltd. (6543) has net assets worth NT$757.61 Million TWD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$1.23 Billion) and total liabilities (NT$469.95 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$757.61 Million |
| % of Total Assets | 61.72% |
| Annual Growth Rate | 3.75% |
| 5-Year Change | 38.64% |
| 10-Year Change | N/A |
| Growth Volatility | 11.68 |
Perfect Medical Industry Co., Ltd. - Net Assets Trend (2019–2024)
This chart illustrates how Perfect Medical Industry Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Perfect Medical Industry Co., Ltd. (2019–2024)
The table below shows the annual net assets of Perfect Medical Industry Co., Ltd. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$803.86 Million | +21.11% |
| 2023-12-31 | NT$663.76 Million | +2.18% |
| 2022-12-31 | NT$649.62 Million | +12.39% |
| 2021-12-31 | NT$578.02 Million | -0.31% |
| 2020-12-31 | NT$579.81 Million | -13.27% |
| 2019-12-31 | NT$668.53 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Perfect Medical Industry Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 12.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$94.36 Million | 11.74% |
| Common Stock | NT$526.63 Million | 65.51% |
| Other Comprehensive Income | NT$69.74 Million | 8.68% |
| Other Components | NT$113.14 Million | 14.07% |
| Total Equity | NT$803.86 Million | 100.00% |
Perfect Medical Industry Co., Ltd. Competitors by Market Cap
The table below lists competitors of Perfect Medical Industry Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Eltek Ltd
NASDAQ:ELTK
|
$25.42 Million |
|
Evergreen Max Cash Capital Berhad
KLSE:0286
|
$25.43 Million |
|
Jiangsu Youli Investment Holding Co Ltd
SHE:000584
|
$25.43 Million |
|
Golden Insurance Brokers Co.,Ltd.
TWO:6028
|
$25.43 Million |
|
Inoviq Ltd
AU:IIQ
|
$25.42 Million |
|
BenQ Medical Technology
TWO:4116
|
$25.42 Million |
|
Dominari Holdings Inc.
NASDAQ:DOMH
|
$25.42 Million |
|
Multicampus Corporation
KQ:067280
|
$25.41 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Perfect Medical Industry Co., Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 663,759,000 to 803,859,000, a change of 140,100,000 (21.1%).
- Net income of 89,123,000 contributed positively to equity growth.
- Dividend payments of 65,141,000 reduced retained earnings.
- New share issuances of 107,870,000 increased equity.
- Other comprehensive income increased equity by 120,747,000.
- Other factors decreased equity by 112,499,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$89.12 Million | +11.09% |
| Dividends Paid | NT$65.14 Million | -8.1% |
| Share Issuances | NT$107.87 Million | +13.42% |
| Other Comprehensive Income | NT$120.75 Million | +15.02% |
| Other Changes | NT$-112.50 Million | -13.99% |
| Total Change | NT$- | 21.11% |
Book Value vs Market Value Analysis
This analysis compares Perfect Medical Industry Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.58x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.98x to 1.58x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | NT$12.55 | NT$24.90 | x |
| 2020-12-31 | NT$13.47 | NT$24.90 | x |
| 2021-12-31 | NT$13.98 | NT$24.90 | x |
| 2022-12-31 | NT$14.43 | NT$24.90 | x |
| 2023-12-31 | NT$14.15 | NT$24.90 | x |
| 2024-12-31 | NT$15.71 | NT$24.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Perfect Medical Industry Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.09%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.98%
- • Asset Turnover: 0.67x
- • Equity Multiplier: 1.39x
- Recent ROE (11.09%) is above the historical average (8.41%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 7.05% | 5.39% | 1.00x | 1.31x | NT$-15.27 Million |
| 2020 | 17.37% | 12.47% | 0.86x | 1.62x | NT$42.71 Million |
| 2021 | 6.71% | 5.35% | 0.70x | 1.79x | NT$-19.03 Million |
| 2022 | 2.20% | 2.11% | 0.71x | 1.47x | NT$-50.69 Million |
| 2023 | 6.04% | 5.46% | 0.74x | 1.49x | NT$-26.29 Million |
| 2024 | 11.09% | 11.98% | 0.67x | 1.39x | NT$8.74 Million |
Industry Comparison
This section compares Perfect Medical Industry Co., Ltd.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,210,573,800
- Average return on equity (ROE) among peers: 11.96%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Perfect Medical Industry Co., Ltd. (6543) | NT$757.61 Million | 7.05% | 0.62x | $25.42 Million |
| St.Shine Optical Co Ltd (1565) | $6.14 Billion | 8.90% | 0.26x | $146.51 Million |
| Nang Kuang Pharmaceutical Co Ltd (1752) | $2.49 Billion | 9.80% | 0.54x | $47.04 Million |
| Maxigen Biotech Inc (1783) | $1.14 Billion | 7.68% | 0.11x | $54.12 Million |
| SciVision Biotech Inc (1786) | $1.90 Billion | 12.77% | 0.24x | $108.60 Million |
| Bioteque (4107) | $3.19 Billion | 14.19% | 0.45x | $198.92 Million |
| Chi Sheng Chemical (4111) | $1.22 Billion | 12.60% | 0.47x | $42.28 Million |
| Sunder Biomedical Tech. Co., Ltd. (4115) | $777.43 Million | 3.74% | 0.69x | $2.14K |
| BenQ Medical Technology (4116) | $1.74 Billion | 10.38% | 0.96x | $25.42 Million |
| Pacific Hospital Supply Co Ltd (4126) | $2.55 Billion | 17.99% | 0.55x | $126.55 Million |
| Unicon Optical Co., Ltd. (4150) | $963.23 Million | 21.57% | 0.59x | $21.52 Million |